MLPA® Kits

For a description how to create and adapt MLPA Kits, that are not available on this page, please have a look at our User Manual MLPA.

Import of SALSA MLPA® kit descriptions via the SEQUENCE Pilot operation "Mixes [master file] / button [Import]".

Mix
Version
Date
Region
Application
Vs. 11
16-03-2010
FGFRs, TWIST, MSX2, ALX4, RUNX2 Craniofacial disorders
Vs. 13
18-01-2012
FGFRs, TWIST, MSX2, ALX4, RUNX2 Craniofacial disorders
Vs. 16
03-01-2013
FGFRs, TWIST, MSX2, ALX4, RUNX2 Craniofacial disorders
Vs. 17
03-02-2014
FGFRs, TWIST, MSX2, ALX4, RUNX2 Craniofacial disorders
Vs. 18
09-08-2017
FGFRs, TWIST, MSX2, ALX4, RUNX2 Craniofacial disorders
Vs. 20
14-01-2010
NF1 17q11.2 Neurofibromatosis
Vs. 21
28-03-2011
NF1 17q11.2 Neurofibromatosis
Vs. 23
21-12-2012
NF1 17q11.2 Neurofibromatosis
Vs. 24
08-01-2013
NF1 17q11.2 Neurofibromatosis
Vs. 25
29-05-2013
NF1 17q11.2 Neurofibromatosis
Vs. 27
03-02-2014
NF1 17q11.2 Neurofibromatosis
Vs. 28
06-05-2014
NF1 17q11.2 Neurofibromatosis
Vs. 29
31-07-2015
NF1 17q11.2 Neurofibromatosis
Vs. 01
06-07-2017
NF1 17q11.2 Neurofibromatosis
Vs. 20
14-01-2010
NF1 17q11.2 Neurofibromatosis
Vs. 21
28-03-2011
NF1 17q11.2 Neurofibromatosis
Vs. 23
21-12-2012
NF1 17q11.2 Neurofibromatosis
Vs. 24
08-01-2013
NF1 17q11.2 Neurofibromatosis
Vs. 25
29-05-2013
NF1 17q11.2 Neurofibromatosis
Vs. 27
03-02-2014
NF1 17q11.2 Neurofibromatosis
Vs. 28
06-05-2014
NF1 17q11.2 Neurofibromatosis
Vs. 29
31-07-2015
NF1 17q11.2 Neurofibromatosis
Vs. 01
06-07-2017
NF1 17q11.2 Neurofibromatosis
Vs. 10
10-05-2011
CDH1 16q22.1 CDH1 or E-cadherin
P083-C1 Vs. 11 18-01-2012 CDH1 16q22.1 CDH1 or E-cadherin
P083-C1 Vs. 12 02-12-2012 CDH1 16q22.1 CDH1 or E-cadherin
P083-C2 Vs. 13 16-04-2014 CDH1 16q22.1 CDH1 or E-cadherin
P083-C2 Vs. 14 21-04-2015 CDH1 16q22.1 CDH1 or E-cadherin
P083-D1 Vs. D1-01 13-09-2017 CDH1 16q22.1 CDH1 or E-cadherin
Vs. 18
14-01-2011
BRCA1 Breast cancer, hereditary
Vs. 19
18-01-2012
BRCA1 Breast cancer, hereditary
Vs. 20
02-12-2012
BRCA1 Breast cancer, hereditary
Vs. 21
01-03-2013
BRCA1 Breast cancer, hereditary
Vs. 22
27-09-2013
BRCA1 Breast cancer, hereditary
Vs. 23
19-06-2014
BRCA1 Breast cancer, hereditary
Vs. 07
12-12-2006
1p, 19q Oligodendroglioma
Vs. 17
02-10-2013
1p, 19q Oligodendroglioma
Vs. 20
02-05-2016
1p, 19q Oligodendroglioma
Vs. 03
17-12-2011
TK2, MPV17, DGUOK, RRM2B, SUCLA2, SUCLG1 mtDNA depletion syndrome
Vs. 04
21-12-2012
TK2, MPV17, DGUOK, RRM2B, SUCLA2, SUCLG1 mtDNA depletion syndrome
Vs. 06
04-12-2015
TK2, MPV17, DGUOK, RRM2B, SUCLA2, SUCLG1 mtDNA depletion syndrome
Vs. 10
11-01-2012
BRCA2 13q12.3 Breast cancer, hereditary
P090-A4 Vs. 11 30-10-2012 BRCA2 13q12.3 Breast cancer, hereditary
P090-A4 Vs. 13 08-01-2013 BRCA2 13q12.3 Breast cancer, hereditary
P090-A4 Vs. 15 11-10-2013 BRCA2 13q12.3 Breast cancer, hereditary
P090-A4 Vs. 16 06-05-2014 BRCA2 13q12.3 Breast cancer, hereditary
P090-A4 Vs. 17 07-11-2014 BRCA2 13q12.3 Breast cancer, hereditary
P090-A4 Vs. 18 09-09-2015 BRCA2 13q12.3 Breast cancer, hereditary
P090-B1 Vs. 19 21-07-2016 BRCA2 13q12.3 Breast cancer, hereditary
P090-B1 Vs. B1-01 05-12-2016 BRCA2 13q12.3 Breast cancer, hereditary
P090-B1 Vs. B1-02 08-06-2017 BRCA2 13q12.3 Breast cancer, hereditary
P090-B1 Vs. B1-03 26-10-2017 BRCA2 13q12.3 Breast cancer, hereditary
Vs. 06
12-12-2009
CFTR 7q31.2 Cystic Fibrosis
Vs. 07
11-01-2012
CFTR 7q31.2 Cystic Fibrosis
Vs. 09
07-01-2013
CFTR 7q31.2 Cystic Fibrosis
Vs. D1-01
02-07-2015 CFTR 7q31.2 Cystic Fibrosis
Vs. D1-02
04-08-2015 CFTR 7q31.2 Cystic Fibrosis
Vs. D1-03
05-05-2017 CFTR 7q31.2 Cystic Fibrosis
Vs. D2-01
13-03-2018 CFTR 7q31.2 Cystic Fibrosis
Vs. 07
30-06-2009
ABCC6 16p13.1 Pseudoxanthoma elasticum
Vs. 10 21-12-2012 ABCC6 16p13.1 Pseudoxanthoma elasticum
Vs. 11 12-08-2015 ABCC6 16p13.1 Pseudoxanthoma elasticum
Vs. 17
22-09-2011
ENG 9q34.1, ALK1 12q13.13, BMPR2 2q33.3 Hemorrhagic telangiectasia, hereditary (HHT), Primary pulmonary hypertension (PPH1)
Vs. 18
08-01-2012
ENG 9q34.1, ALK1 12q13.13, BMPR2 2q33.3 Hemorrhagic telangiectasia, hereditary (HHT), Primary pulmonary hypertension (PPH1)
Vs. 19
02-12-2012
ENG 9q34.1, ALK1 12q13.13, BMPR2 2q33.3 Hemorrhagic telangiectasia, hereditary (HHT), Primary pulmonary hypertension (PPH1)
Vs. 20
22-07-2015
ENG 9q34.1, ALK1 12q13.13, BMPR2 2q33.3 Hemorrhagic telangiectasia, hereditary (HHT), Primary pulmonary hypertension (PPH1)
Vs. 21
15-01-2015
ENG 9q34.1, ALK1 12q13.13, BMPR2 2q33.3 Hemorrhagic telangiectasia, hereditary (HHT), Primary pulmonary hypertension (PPH1)
Vs. 11
24-12-2011
MEFV 16p13.3 Mediterranean fever, familial (MEFV)
Vs. 13
11-01-2013
MEFV 16p13.3 Mediterranean fever, familial (MEFV)
Vs. 14
13-05-2015
MEFV 16p13.3 Mediterranean fever, familial (MEFV)
Vs. 14
23-07-2010
Chr. 13, 18, 21, X, Y Down syndrome, Edwards syndrome, Patau syndrome
Vs. 16
19-11-2011
Chr. 13, 18, 21, X, Y Down syndrome, Edwards syndrome, Patau syndrome
Vs. 21
27-11-2014
Chr. 13, 18, 21, X, Y Down syndrome, Edwards syndrome, Patau syndrome
Vs. A4-01
21-09-2016
Chr. 13, 18, 21, X, Y Down syndrome, Edwards syndrome, Patau syndrome
Vs. 05
06-07-2006
various Mental retardation, Wolf-Hirschlorn, Cri du Chat, Langer-Giedon, WAGR, Rubinstein-Taybi, Down, Kabuki
Vs. 12
20-10-2010
various Mental retardation, Wolf-Hirschlorn, Cri du Chat, Langer-Giedon, WAGR, Rubinstein-Taybi, Down, Kabuki
Vs. 14
02-12-2012
various Mental retardation, Wolf-Hirschlorn, Cri du Chat, Langer-Giedon, WAGR, Rubinstein-Taybi, Down, Kabuki
Vs. 17
16-10-2015
various Mental retardation, Wolf-Hirschlorn, Cri du Chat, Langer-Giedon, WAGR, Rubinstein-Taybi, Down, Kabuki
Vs. 15
24-12-2011
ATP7B 13q14.3 Wilson disease
P098-C1 Vs. 16 21-08-2012 ATP7B 13q14.3 Wilson disease
P098-C1 Vs. 17 21-12-2012 ATP7B 13q14.3 Wilson disease
P098-C1 Vs. 18 22-07-2015 ATP7B 13q14.3 Wilson disease
P098-C2 Vs. 19 11-11-2016 ATP7B 13q14.3 Wilson disease
Vs. 10
08-02-2011
TH 11p15.5, GCH114q22, SGCE 7q21 Dopa-responsive dystonia, Segawa disease; Myoclonus-dystonia syndrome
Vs. 11
24-12-2011
TH 11p15.5, GCH114q22, SGCE 7q21 Dopa-responsive dystonia, Segawa disease; Myoclonus-dystonia syndrome
Vs. 13
08-04-2013
TH 11p15.5, GCH114q22, SGCE 7q21 Dopa-responsive dystonia, Segawa disease; Myoclonus-dystonia syndrome
Vs. 14
04-02-2014
TH 11p15.5, GCH114q22, SGCE 7q21 Dopa-responsive dystonia, Segawa disease; Myoclonus-dystonia syndrome
Vs. 15
10-01-2017
TH 11p15.5, GCH114q22, SGCE 7q21 Dopa-responsive dystonia, Segawa disease; Myoclonus-dystonia syndrome
Vs. 16
20-06-2017
TH 11p15.5, GCH114q22, SGCE 7q21 Dopa-responsive dystonia, Segawa disease; Myoclonus-dystonia syndrome